STAT3 and colorectal carcinoma: In summary, we have established proof of concept for the successful application of the PROTAC strategy to target otherwise “undruggable” proteins by rapidly and reversibly degrading endogenous STAT3 protein both in vitro and in vivo for HNSCC and CRC.